The information in these podcasts should not be construed as medical advice. Please consult with your health care provider regarding your medical decisions and treatment. The listed resources are not intended to be endorsements.
SEASON 8 : EPISODE 0
Welcome to Season 8 of the Marrow Masters Podcast, sponsored by Omeros Corporation and Incyte. Season 8 of our show focuses on clinical trials. We’re covering how to find them, what to expect, and how survivors have benefited from them. We also talk to healthcare professionals about how these oncology clinical trials are conducted and monitored, safely. Our goal is to answer as many of your questions as possible.
SEASON 8 : EPISODE 1
Survivor Aisha Stokes walks us through the decision to enroll in this trial just before an upcoming birthday would have made her ineligible. Following pheresis, she underwent an intense four day chemotherapy treatment, followed by a stem cell transplant, with her own modified cells.
SEASON 8 : EPISODE 2
In this episode, Dr. Cutler discusses th common myths around clinical trials, including patients who are concerned about placebo, and how they also benefit from the trials. Any clinical trial participant should put their own health first, ahead of any altruistic intentions. And not all trials involve new therapies. You can participate in a cohort study, which only follows your existing plan for research purposes.
SEASON 8 : EPISODE 3
Late admission into a clinical trial got Jacey to remission the first time. After a relapse, she underwent a double cord transplant when no donor could be found. Yet another clinical trial bought her more time until, following yet another relapse, Jacey found a match, and has been in remission ever since.
SEASON 8 : EPISODE 4
This season we are talking to doctors and clinical trial participants. But today we get a different perspective. Stacey Brown manages clinical research at Northside Hospital Cancer Institute. She’s uniquely qualified to discuss what goes into an institution joining a clinical trial, as well as everything patients can expect throughout the process.
SEASON 8 : EPISODE 5
Today Gleevec is an incredibly common cancer treatment. But like every drug on the market, it went through clinical trials more than two decades ago. Our guest today, Mel Mann, was the second person to receive the drug, back in 1998. And it saved his life.
SEASON 8 : EPISODE 6
Dr. Schroeder also breaks down some of the common misconceptions around clinical trials. This includes hesitation around placebo, the idea of being a “guinea pig,” and the cost of treatment – which is often covered by the entities running the trial. Also, some folks believe that trial drugs are not as good as what’s already been approved. This isn’t true; by participating in a trial, you might gain early access to a therapy that provides better outcomes.
SEASON 8 : EPISODE 7
Survivor Marilyn Zagha-Keeshan joins us today. An immunoblastic T-cell lymphoma survivor, Marilyn volunteered for not one, but two clinical trials. She talks about the helpless feeling that came with her cancer diagnosis, but the empowering feeling that came with volunteering for clinical trials.